This Article Figures Only Full Text Full Text (PDF) View Current Clinical Collection-Atrial Fibrillation View Genuine Article Video Part One View CVN News Brief Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Echahidi, N. Articles by Mathieu, P. Search for Related Content PubMed Articles by Echahidi, N. Articles by Mathieu, P.

FOCUS ISSUE: ATRIAL FIBRILLATION: STATE-OF-THE-ART PAPER

Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery

Najmeddine Echahidi, MD^_*, Philippe Pibarot, DVM, PhD, FACC, FAHA^_*,1, Gilles O’Hara, MD, FACC^_* and Patrick Mathieu, MD, FRCSC^,_*,2

^_* Department of Medicine, Laval Hospital Research Center/Quebec Heart Institute, Laval University, Ste-Foy, Quebec, Canada
Department of Surgery, Laval Hospital Research Center/Quebec Heart Institute, Laval University, Ste-Foy, Quebec, Canada.

Manuscript received July 3, 2007; revised manuscript received September 21, 2007, accepted October 7, 2007.

^_* Reprint requests and correspondence: Dr. Patrick Mathieu, Hôpital Laval, 2725 Chemin Ste-Foy, Quebec, Canada, G1V-4G5. (Email: patrick.mathieu{at}chg.ulaval.ca).

Post-operative atrial fibrillation (POAF) is a frequent complication occurring in 30% to 50% of patients after cardiac surgery. It is associated with an increased risk of mortality and morbidity, predisposes patients to a higher risk of stroke, requires additional treatment, and increases the costs of the post-operative care. The aim of this review is to present the current state of knowledge about the risk factors, mechanisms, prevention, and treatment of this complication. In addition to the well known risk factors for the development of POAF such as age, left atrial enlargement, and valvular surgery, new metabolic risk factors related to visceral obesity have been identified. With regard to the prevention of POAF, beta-blocker drugs are effective and safe and can be used in most patients, whereas amiodarone can be added in high-risk patients. Biatrial pacing was shown to be effective; however, its complexity might limit its application. Although there are only few data regarding the usefulness of magnesium, statins, N-3 polyunsaturated fatty acids, and corticosteroids, their addition to beta-blocker drugs might be of benefit for further reducing POAF. Treatment includes the use of an AV nodal blocking agent to achieve the rate control. If AF does not spontaneously convert to sinus rhythm within 24 h, anticoagulation should be initiated and a rhythm control strategy should be attempted. More investigations are warranted to explore mechanisms by which POAF occurs. This new knowledge would undoubtedly translate into a more efficient prevention and treatment of this common post-operative complication that is associated with a major health and economic burden.

Abbreviations and Acronyms   AF = atrial fibrillation   AV = atrioventricular   CABG = coronary artery bypass graft   CI = confidence interval   HR = hazard ratio   OR = odds ratio   POAF = post-operative atrial fibrillation   PUFAs = N-3 polyunsaturated fatty acids

This article has been cited by other articles:

				A. Miceli, C. Fino, B. Fiorani, M. Yeatman, P. Narayan, G. D. Angelini, and M. Caputo Effects of Preoperative Statin Treatment on the Incidence of Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting. Ann. Thorac. Surg., June 1, 2009; 87(6): 1853 - 1858. [Abstract] [Full Text] [PDF]

				E. I. Rossman, K. Liu, G. A. Morgan, R. E. Swillo, J. A. Krueger, S. J. Gardell, J. Butera, M. Gruver, J. Kantrowitz, H. S. Feldman, et al. The Gap Junction Modifier, GAP-134 [(2S,4R)-1-(2-Aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic Acid], Improves Conduction and Reduces Atrial Fibrillation/Flutter in the Canine Sterile Pericarditis Model J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 1127 - 1133. [Abstract] [Full Text] [PDF]

				N. Girerd, P. Pibarot, D. Fournier, P. Daleau, P. Voisine, G. O'Hara, J.-P. Despres, and P. Mathieu Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery Eur. Heart J., May 2, 2009; 30(10): 1270 - 1278. [Abstract] [Full Text] [PDF]

				C. W. Khoo and G. Y. H. Lip Acute Management of Atrial Fibrillation Chest, March 1, 2009; 135(3): 849 - 859. [Abstract] [Full Text] [PDF]

				A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al. Highlights of the Year in JACC 2008. J. Am. Coll. Cardiol., January 27, 2009; 53(4): 373 - 398. [Full Text] [PDF]

				J. R. Kapoor Combination Prophylactic Therapy for Post-Operative Atrial Fibrillation J. Am. Coll. Cardiol., July 29, 2008; 52(5): 397 - 397. [Full Text] [PDF]

				N. Echahidi, P. Pibarot, G. O'Hara, and P. Mathieu Reply J. Am. Coll. Cardiol., July 29, 2008; 52(5): 397 - 398. [Full Text] [PDF]